August 5, 2011
Revenue Cycle Inc. Forges Partnership With D3 Oncology Solutions for the Newly Launched SABRE Program
AUSTIN, Texas, Aug. 5, 2011 /PRNewswire/ -- Revenue Cycle Inc. announces that it has forged a strategic collaboration with D3 Oncology Solutions for SABRE financial consulting and support.
In this newly formed partnership, Revenue Cycle Inc. will research and educate D3 Oncology Solutions clients in proper coding, billing, documentation, and compliance for SABRE, D3's comprehensive program that helps cancer centers safely and effectively implement a new SRS/SBRT (stereotactic radiosurgery/stereotactic body radiotherapy) program for improved patient outcomes. "We're proud to forge this strategic collaboration with D3 to facilitate and streamline the implementation of their SABRE program," says Ron DiGiaimo, CEO of Revenue Cycle Inc. "The proliferation of radiosurgery in the US is a testimony to the associated benefits patients receive from this modality. We are excited to play a role in helping D3 expand this service line."
Founded in 2002, D3 (http://www.d3onc.com) is an affiliate of UPMC, an integrated global health enterprise headquartered in Pittsburgh and one of the leading health systems in the country. Its mission is to develop and deliver leading edge solutions that accelerate the quality, safety, efficiency, and outcomes of cancer patients' care at radiation and medical oncology centers. D3 has assisted hundreds of cancer centers worldwide in delivering advanced radiation therapy.
Revenue Cycle Inc.'s on-site, hands-on education will include topics related to SRS/SBRT process of care, financial counseling, reference materials, billing and determination of covered diagnosis for requested SRS/SBRT procedures for each of the customer's top payers. Revenue Cycle Inc. will provide a complete billing and coding guide to D3 Oncology Solutions customers and will assist in ensuring that initial cases stemming from this strategic collaboration are accurate and compliant. "Revenue Cycle's consulting expertise will be invaluable in optimizing the success of our SABRE program," says Kathy Lokay, president and CEO of D3 Oncology Solutions. "We look forward to working with them."
For more information about Revenue Cycle Inc., visit http://www.revenuecycleinc.com or call 512.583.2000. For more information about D3 Oncology Solutions, visit http://www.d3onc.com or call 412.365.0710.
This release was issued on behalf of the above organization by Send2PressÃ®, a unit of NeotropeÃ®. http://www.Send2Press.com
SOURCE Revenue Cycle Inc.